Cargando…

Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients

Multiple sclerosis (MS) is a chronic, severe disease, characterized by a progressive alteration in neuronal transmission, which decreases personal independence and quality of life (QoL). This study aimed to investigate the relationship between QoL and personal autonomy in patients with MS, as well a...

Descripción completa

Detalles Bibliográficos
Autores principales: Padureanu, Rodica, Albu, Carmen Valeria, Pirici, Ionica, Mititelu, Radu Razvan, Subtirelu, Mihaela Simona, Turcu-Stiolica, Razvan Aurelian, Sintonen, Harri, Padureanu, Vlad, Turcu-Stiolica, Adina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290289/
https://www.ncbi.nlm.nih.gov/pubmed/32380685
http://dx.doi.org/10.3390/jcm9051349
_version_ 1783545641032482816
author Padureanu, Rodica
Albu, Carmen Valeria
Pirici, Ionica
Mititelu, Radu Razvan
Subtirelu, Mihaela Simona
Turcu-Stiolica, Razvan Aurelian
Sintonen, Harri
Padureanu, Vlad
Turcu-Stiolica, Adina
author_facet Padureanu, Rodica
Albu, Carmen Valeria
Pirici, Ionica
Mititelu, Radu Razvan
Subtirelu, Mihaela Simona
Turcu-Stiolica, Razvan Aurelian
Sintonen, Harri
Padureanu, Vlad
Turcu-Stiolica, Adina
author_sort Padureanu, Rodica
collection PubMed
description Multiple sclerosis (MS) is a chronic, severe disease, characterized by a progressive alteration in neuronal transmission, which decreases personal independence and quality of life (QoL). This study aimed to investigate the relationship between QoL and personal autonomy in patients with MS, as well as its correlation with age, educational level, and diseases severity. Twenty-six MS patients were followed-up for six months. All patients completed the 15D questionnaire two times: at T0, when they started a new treatment, and at T1 after six months of treatment. At the end point, all patients completed the Personal Autonomy Questionnaire. The average patient age was 43 years (SD = 10), and 89% of them were female. The mean severity and duration of MS were 3.5 (SD = 1.75) and 9.5 (SD = 5.1), respectively. The average QoL of MS patients at T0 was 0.66 (SD = 0.18), and that at T1 was 0.71 (SD = 0.16). The scores of patients with different types of MS, i.e., relapsing–remitting MS (RRMS) or secondary progressive MS (SPMS), were compared. SPMS patients were older than RRMS patients (mean age 47.5 vs. 39.7 years; p = 0.032), and more RRMS patients were working (0.014). SPMS patients described the same QoL and personal autonomy as RRMS patients. Results from bivariate correlation analyses showed a significant relationship between QoL and age, education, and severity of MS. Also, the analysis showed no significant correlation between QoL and personal autonomy.
format Online
Article
Text
id pubmed-7290289
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72902892020-06-15 Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients Padureanu, Rodica Albu, Carmen Valeria Pirici, Ionica Mititelu, Radu Razvan Subtirelu, Mihaela Simona Turcu-Stiolica, Razvan Aurelian Sintonen, Harri Padureanu, Vlad Turcu-Stiolica, Adina J Clin Med Article Multiple sclerosis (MS) is a chronic, severe disease, characterized by a progressive alteration in neuronal transmission, which decreases personal independence and quality of life (QoL). This study aimed to investigate the relationship between QoL and personal autonomy in patients with MS, as well as its correlation with age, educational level, and diseases severity. Twenty-six MS patients were followed-up for six months. All patients completed the 15D questionnaire two times: at T0, when they started a new treatment, and at T1 after six months of treatment. At the end point, all patients completed the Personal Autonomy Questionnaire. The average patient age was 43 years (SD = 10), and 89% of them were female. The mean severity and duration of MS were 3.5 (SD = 1.75) and 9.5 (SD = 5.1), respectively. The average QoL of MS patients at T0 was 0.66 (SD = 0.18), and that at T1 was 0.71 (SD = 0.16). The scores of patients with different types of MS, i.e., relapsing–remitting MS (RRMS) or secondary progressive MS (SPMS), were compared. SPMS patients were older than RRMS patients (mean age 47.5 vs. 39.7 years; p = 0.032), and more RRMS patients were working (0.014). SPMS patients described the same QoL and personal autonomy as RRMS patients. Results from bivariate correlation analyses showed a significant relationship between QoL and age, education, and severity of MS. Also, the analysis showed no significant correlation between QoL and personal autonomy. MDPI 2020-05-05 /pmc/articles/PMC7290289/ /pubmed/32380685 http://dx.doi.org/10.3390/jcm9051349 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Padureanu, Rodica
Albu, Carmen Valeria
Pirici, Ionica
Mititelu, Radu Razvan
Subtirelu, Mihaela Simona
Turcu-Stiolica, Razvan Aurelian
Sintonen, Harri
Padureanu, Vlad
Turcu-Stiolica, Adina
Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients
title Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients
title_full Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients
title_fullStr Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients
title_full_unstemmed Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients
title_short Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients
title_sort personal autonomy as quality of life predictor for multiple sclerosis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290289/
https://www.ncbi.nlm.nih.gov/pubmed/32380685
http://dx.doi.org/10.3390/jcm9051349
work_keys_str_mv AT padureanurodica personalautonomyasqualityoflifepredictorformultiplesclerosispatients
AT albucarmenvaleria personalautonomyasqualityoflifepredictorformultiplesclerosispatients
AT piriciionica personalautonomyasqualityoflifepredictorformultiplesclerosispatients
AT mititeluradurazvan personalautonomyasqualityoflifepredictorformultiplesclerosispatients
AT subtirelumihaelasimona personalautonomyasqualityoflifepredictorformultiplesclerosispatients
AT turcustiolicarazvanaurelian personalautonomyasqualityoflifepredictorformultiplesclerosispatients
AT sintonenharri personalautonomyasqualityoflifepredictorformultiplesclerosispatients
AT padureanuvlad personalautonomyasqualityoflifepredictorformultiplesclerosispatients
AT turcustiolicaadina personalautonomyasqualityoflifepredictorformultiplesclerosispatients